DIETHYLENE TRIAMINE PENTA ACETIC ACID AR 99%
diethylenetriamine pentaacetic acid (DTPA) is the radiopharmaceutical used for the
evaluation of glomerular filtration function.
Diethylenetriaminepentaacetic acid has been used:
Effects of DTPA are mediated exclusively by zinc deficiency; zinc supplementation negates developmental (and other) toxicity.
DTPA (Diethylenetriamine pentaacetate) is a medicine that can bind to radioactive plutonium, americium, and curium to decrease the amount of time it takes to get radioactive plutonium, americium, and curium out of the body.
Diethylenetriaminepentaacetic acid has been used:
for cofilin activity assay
to determine the specificity of superoxide in the transverse aortic constriction (TAC) hearts
for Europium bead-based detection assays
to detect reduced (S- active) or irreversibly oxidized (SO3H inactive) tyrosine-protein phosphatase non-receptor type 6 (SHP-1) in thymocytes